rs3856090

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.769+428G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.341 in 151,170 control chromosomes in the GnomAD database, including 9,164 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 9164 hom., cov: 32)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.45

Publications

3 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.445 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.769+428G>A intron_variant Intron 5 of 47 ENST00000367573.7 NP_001192222.1 Q15878-1Q59FG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.769+428G>A intron_variant Intron 5 of 47 1 NM_001205293.3 ENSP00000356545.2 Q15878-1
CACNA1EENST00000360108.7 linkc.769+428G>A intron_variant Intron 5 of 46 5 ENSP00000353222.3 F8W9Z1
CACNA1EENST00000367570.6 linkc.769+428G>A intron_variant Intron 5 of 46 1 ENSP00000356542.1 Q15878-3
CACNA1EENST00000621791.4 linkc.769+428G>A intron_variant Intron 5 of 45 1 ENSP00000481619.1 Q15878-2
CACNA1EENST00000524607.6 linkc.1204+428G>A intron_variant Intron 7 of 11 5 ENSP00000432038.2 E9PIE8

Frequencies

GnomAD3 genomes
AF:
0.341
AC:
51535
AN:
151066
Hom.:
9160
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.240
Gnomad AMI
AF:
0.423
Gnomad AMR
AF:
0.453
Gnomad ASJ
AF:
0.396
Gnomad EAS
AF:
0.313
Gnomad SAS
AF:
0.461
Gnomad FIN
AF:
0.339
Gnomad MID
AF:
0.433
Gnomad NFE
AF:
0.366
Gnomad OTH
AF:
0.394
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.341
AC:
51539
AN:
151170
Hom.:
9164
Cov.:
32
AF XY:
0.341
AC XY:
25160
AN XY:
73826
show subpopulations
African (AFR)
AF:
0.239
AC:
9868
AN:
41218
American (AMR)
AF:
0.454
AC:
6892
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
0.396
AC:
1368
AN:
3456
East Asian (EAS)
AF:
0.312
AC:
1605
AN:
5152
South Asian (SAS)
AF:
0.460
AC:
2203
AN:
4786
European-Finnish (FIN)
AF:
0.339
AC:
3507
AN:
10332
Middle Eastern (MID)
AF:
0.428
AC:
125
AN:
292
European-Non Finnish (NFE)
AF:
0.366
AC:
24768
AN:
67734
Other (OTH)
AF:
0.391
AC:
820
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
1684
3369
5053
6738
8422
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
514
1028
1542
2056
2570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.339
Hom.:
4601
Bravo
AF:
0.346
Asia WGS
AF:
0.413
AC:
1430
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.28
DANN
Benign
0.19
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3856090; hg19: chr1-181548788; COSMIC: COSV107431191; API